You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 96 No. 6, DECEMBER 1955 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (22)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Tubeless Gastric Analysis

An Evaluation of Azure A Indicator Compound

JOHN T. GALAMBOS, M.D.; JOSEPH B. KIRSNER, M.D.

AMA Arch Intern Med. 1955;96(6):752-756.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Several attempts have been made in the past to develop a simple yet accurate method for the detection of hydrochloric acid in the gastric content without intubation.* A quinine indicator resin proved to be useful for this purpose {dagger}; however, certain vitamins, steroids, and quinine-containing drinks or medication, by increasing urinary fluorescence, produced falsely high results; the rather troublesome and time-consuming extraction technique for the detection of quinine in the urine was an additional disadvantage.

The introduction of an azure A ionexchange compound by Segal and coworkers 5 seemed to overcome the principal disadvantage of the quinine resin and to reflect the presence or absence of hydrochloric acid satisfactorily. The present report describes our experience with this compound as an index of the presence or absence of hydrochloric acid in the gastric content of 104 patients.

MATERIAL AND METHODS

The patients swallowed a Levin or Rehfuss tube and underwent the . . . [Full Text PDF of this Article]


Author Affiliations

Chicago


Footnotes

Submitted for publication July 13, 1955.

The azure A indicator compound was supplied by E. R. Squibb & Sons.

Department of Medicine, University of Chicago. United States Public Health Service Research Fellow of the National Cancer Institute (Dr. Galambos).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1955 American Medical Association. All Rights Reserved.